PDL BIOPHARMA INC's ticker is and the CUSIP is 69329YAF1. A total of 34 filers reported holding PDL BIOPHARMA INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $691,000 | -82.5% | 765,000 | -84.5% | 0.00% | -75.0% |
| Q4 2015 | $3,944,000 | -40.3% | 4,926,000 | -34.2% | 0.00% | -33.3% |
| Q3 2015 | $6,601,000 | +41.6% | 7,491,000 | +52.4% | 0.01% | +50.0% |
| Q2 2015 | $4,661,000 | +11.9% | 4,916,000 | +12.9% | 0.00% | 0.0% |
| Q1 2015 | $4,166,000 | -26.1% | 4,354,000 | -26.2% | 0.00% | -20.0% |
| Q4 2014 | $5,639,000 | -2.2% | 5,897,000 | -0.4% | 0.01% | 0.0% |
| Q3 2014 | $5,767,000 | +154.3% | 5,922,000 | +198.9% | 0.01% | +150.0% |
| Q2 2014 | $2,268,000 | – | 1,981,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|